Dirt low MC of £15 M /Cash ~£10.5 M / 3 Products in Pipeline including a Potential BIG Blockbuster and uuuuuup she goes again…there is no resistance untill around 25p
The conundrum I think Poland’s on the list of them now unless I’m misunderstanding it.
The conundrum I remember last time I checked (quite recent) there were 3 countries and now there are 4. I can’t remember which one is the most recent one. Poland should be on there pretty soon.
The conundrum No problem lol easily done! Had me going for a second though haha
The conundrum Which is the latest country, Aberdeen? If I remember rightly, Bulgaria was the first which came before xmas. The other centres are: clinicaltrials.gov Clinical Trial Using Topically Applied Glyceryl Trinitrate (GTN) for the... Clinical Trial Using Topically Applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction - Full Text View. I wonder if STADA are in the mix for MED. Would be a massive boost if TPR was approved if that’s the case. Again I have to jog my memory regarding previous years’ discussions but I think STADA specialise in generics. Will have to look into it again.
The conundrum Apologies, really sorry. I have both SLA and FUM in my LSE portfolio and reacted too quickly to the news item.
The conundrum Unfortunately you are mistaken. If you look at your post correctly it is not futura but future plc two very different companies.
The conundrum Thank you, oddly enough on LSE website I see no RNS past 20th Feb.
The conundrum [link]
The conundrum Where?
The conundrum Also nice to see that SLA has gone today from a non-disclosable level (<3%) to 5.26% of shares in FUM
Dirt low MC of £15 M /Cash ~£10.5 M / 3 Products in Pipeline including a Potential BIG Blockbuster Market cap 27 million /Cash 10.5 million / Potency Drug with 2 BILLION Market potential /CSD500 Condom approved in Europe and many Countries outside of Europa + more Approvals & Licensing deals coming / TPR100 (Topical Gel for Pain ) first approval expected next Quarter = POTENTIAL 10++ BAGGER GEM RALLYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY Market potential The market for ED undoubtedly offers Futura a huge opportunity. Independent market research conducted on the company™s behalf indicates MED2005 could generate potentially $1bn (£781m) in annual sales from both prescription and over-the-counter sales priced at $5 (Â£3.90) per dose. The prescription market alone was worth over $5.6bn in 2016. The profit margin on the product, which will have patent protection, is massive, too, as the cost is expected to be under ‚¬0.30 per dose (26.5p). Extensive work is being carried out to produce the chemistry, manufacturing and controls package required for regulatory submission and to establish the supply chain. A huge addressable market and profit margin makes this a blue-sky opportunity.
Dirt low MC of £15 M /Cash ~£10.5 M / 3 Products in Pipeline including a Potential BIG Blockbuster uuuuuup she goes ,still think that takeover or partnership will happen before phase 3 readout …phase 3 ongoing for around 5 months now maybe those who are interested in med like what they see
The conundrum Nice to see phase 3 approval in another country. onwards and upwards with recruitment
The conundrum Looking back at TPR updates and the expected timing of approval, I’ve now convinced myself that Thornton & Ross have received preliminary “positive” responses from the MHRA, possibly having to address the odd few issues (a similar carry on happened when CSD was obtaining the CE Mark approval} hence getting the ball rolling by registering “Dermamax”. All IMO of course. So I’m hoping approval will be granted very shortly. This will not only trigger a milestone payment, but could open the door to other deals outside the UK which apparently are under ongoing discussion which may resolve the Part 2 Phase 3 MED funding if further TPR licensing deals achieve decent upfront payments. We should also be getting the Final Results for 2018 shortly (last year’s were released on 14/3/2018) but unusually no prior notification of the date as yet - FUM are usually very efficient in letting us know.